Proteomic Analysis of Changes Mediating Tolerance to Dopamine D1 Agonists: Implications for Parkinson's Disease (PD)

被引：0
|
作者：
Boyd, Kevin N. [1 ]
VanGuilder, Heather D. [1 ]
Freeman, Willard M. [1 ]
Mailman, Richard B. [1 ]
机构：
[1] Penn State Coll Med, Hershey, PA USA
来源：
FASEB JOURNAL | 2011年 / 25卷
关键词：
D O I：
暂无
中图分类号：
Q5 [生物化学]; Q7 [分子生物学];
学科分类号：
071010 ; 081704 ;
摘要：
引用
收藏
页数：1
相关论文
共 50 条
  • [1] Specificity of striatal dopamine D1 system in humans: implications for clinical use of D1 receptor-agonists in Parkinson's disease
    Goto, Satoshi
    [J]. FRONTIERS IN HUMAN NEUROSCIENCE, 2023, 17
  • [2] Dopamine D1 receptor agonists -: The way forward for the treatment of Parkinson's disease?
    Vermeulen, RJ
    Drukarch, B
    Wolters, EC
    Stoof, JC
    [J]. CNS DRUGS, 1999, 11 (02) : 83 - 91
  • [3] Dopamine D1 Agonists: First Potential Treatment for Late-Stage Parkinson's Disease
    Lewis, Mechelle M.
    Van Scoy, Lauren J.
    De Jesus, Sol
    Hakun, Jonathan G.
    Eslinger, Paul J.
    Fernandez-Mendoza, Julio
    Kong, Lan
    Yang, Yang
    Snyder, Bethany L.
    Loktionova, Natalia
    Duvvuri, Sridhar
    Gray, David L.
    Huang, Xuemei
    Mailman, Richard B.
    [J]. BIOMOLECULES, 2023, 13 (05)
  • [4] Central dopaminergic D1 agonists in the treatment of Parkinson's disease
    Soubrouillard, C
    Lombardo, C
    Rascol, O
    Bruguerolle, B
    Blin, O
    [J]. THERAPIE, 1997, 52 (06): : 527 - 534
  • [5] Dopamine D1 receptor expression in human basal ganglia and changes in Parkinson's disease
    Hurley, MJ
    Mash, DC
    Jenner, P
    [J]. MOLECULAR BRAIN RESEARCH, 2001, 87 (02): : 271 - 279
  • [6] The role of D1 dopamine receptor activation in Parkinson's disease: insight from apomorphine and other clinically used dopamine agonists
    Mailman, R. B.
    Heinzen, E.
    Huang, X.
    [J]. MOVEMENT DISORDERS, 2006, 21 : S643 - S643
  • [7] Differential effects of D1 and D2 agonists in MPTP,treated primates:: Functional implications for Parkinson's disease
    Boyce, S
    Rupniak, NMJ
    Steventon, MJ
    Iversen, SD
    [J]. NEUROLOGY, 2001, 57 (10) : S27 - S33
  • [8] Role and regulation of dopamine D1 receptors in the striatum:: implications for the genesis of dyskinesia in Parkinson's disease.
    Corvol, J. -C.
    Girault, J. -A.
    Herve, D.
    [J]. REVUE NEUROLOGIQUE, 2006, 162 (6-7) : 691 - 702
  • [9] Comparison of the D1 dopamine full agonists, dihydrexidine and doxanthrine, in the 6-OHDA rat model of Parkinson's disease
    McCorvy, John D.
    Watts, Val J.
    Nichols, David E.
    [J]. PSYCHOPHARMACOLOGY, 2012, 222 (01) : 81 - 87
  • [10] Efficacy of dopamine D1 receptor agonists A-86929 and ABT-431 in animal models of Parkinson's disease
    Shiosaki, K
    Asin, KE
    Bedard, P
    Britton, DR
    Jenner, P
    Lin, CW
    Michaelides, M
    Williams, M
    [J]. DOPAMINE RECEPTOR SUBTYPES: FROM BASIC SCIENCE TO CLINICAL APPLICATION, 1998, 19 : 84 - 97
12345